J Korean Ophthalmol Soc > Volume 53(9); 2012 > Article
Journal of the Korean Ophthalmological Society 2012;53(9):1276-1284.
DOI: https://doi.org/10.3341/jkos.2012.53.9.1276    Published online September 15, 2012.
Short-Term Visual Outcomes According to Patterns of Macular Edema in Retinal Vein Occlusion Patients.
Ka Hee Park, In Ho Rho
Department of Ophthalmology, Soonchunhyang University College of Medicine, Cheonan, Korea. mdroh@daum.net
망막정맥폐쇄환자에서 황반부종의 양상에 따른 단기 시력예후
박가희⋅노인호
Department of Ophthalmology, Soonchunhyang University College of Medicine, Cheonan, Korea
Abstract
PURPOSE
To study the short-term visual outcomes affected by the patterns of macular edema in retinal vein occlusion patients. METHODS: In a retrospective study, 33 eyes of 33 consecutive patients with macular edema from retinal vein occlusion received an intravitreal injection of bevacizumab. Macular edema was classified according to OCT patterns and the effect on visual outcome evaluated: Diffuse macular edema (DME) vs. focal macular edema (FME), and macular edema with serous retinal detachment (SRD) vs. macular edema without serous retinal detachment (non-SRD). RESULTS: Nine patients had CRVO, 24 patients had BRVO and the follow-up period was 3.6 months. In the FME group, the mean baseline BCVA was 0.61 +/- 0.34 and the final BCVA was 0.26 +/- 0.29, a difference that was statistically significant (p < 0.01). In the DME group, the mean baseline BCVA was 0.85 +/- 0.44 and the final BCVA was 0.73 +/- 0.37, a difference that was not statistically significant (p = 0.07). In the non-SRD group, the mean baseline BCVA was 0.76 +/- 0.43 and the final BCVA was 0.38 +/- 0.36, a difference that was statistically significant (p < 0.01). In the SRD group, the mean baseline BCVA was 0.73 +/- 0.40 and the final BCVA was 0.64 +/- 0.42, a difference that was not statistically significant (p = 0.07). CONCLUSIONS: Visual outcome was significantly better in the FME and non-SRD groups. The patterns of macular edema measured according to OCT were a prognostic factor for visual outcome.
Key Words: Bevacizumab;Macular edema;Optical coherence tomography;Retinal vein occlusion


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next